Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • JakobHedegaard
    Member
    • Mar 2008
    • 62

    #1

    Contamination with bacterial rRNA

    We have done Ribo-Zero-Human rRNA depletion of total-RNA from human clinical samples followed by ScriptSeq library prep and HiSeq sequencing. But it turned out that app 50 % of the reads were of bacterial rRNA origin.
    Anyone observed something similar?
    /Jakob
  • Olaf Blue
    Member
    • Nov 2010
    • 58

    #2
    Ribo Zero combination H/MR and bacteria

    Hello Jakob,

    The "fix" actually is simple, and it would involve using the RZ Kits in tandem. After the total RNA depletion, you can use RZ Human with the RZ bacteria (three kinds available - Gram Positive, Gram negative and "meta-Bacterial" for both gram positive and negative) in a single step (mixing the rRNA removal solutions in a 50/50 mix) or running the depletions sequentially.

    For the "combined" reaction, after total RNA purification simply use a mix of the RZ Human rRNA removal soln with the bacterial rRNA removal soln of choice. Use 5 µl of the human and 5 µl of the bacterial (total volume of 10 µl for 5 µg input). Them simply continue after the incubation at 50C, and follow the bead-binding and filtration as per normal.

    Only caveat here is to not use more than 2.5 µg of total "mixed" sample RNA (due to the overall reduction in the rRNA removal solution from what the standard volume is used in a "normal" depletion.

    If you need further clarification, do contact me.

    olaf

    Epicentre tech support

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      Today, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 05:39 AM
    0 responses
    9 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 09:56 AM
    0 responses
    11 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 09-29-2026, 09:51 AM
    0 responses
    77 views
    0 reactions
    Last Post SEQadmin2  
    Working...